Agena Bioscience^®新闻报道

Agena Bioscience and Heartgenetics Announce Co-Marketing Alliance More

HEARTDECODE^® Software and Assays Designed for Use with the MassARRAY^® DX SystemSan Diego, CA,...

Agena Bioscience and Intermountain Healthcare Announce Research Collaboration to Advance Precision Medicine More

SAN DIEGO, CA, AND SAINT GEORGE, UTAH – Agena Bioscience and Intermountain Healthcare announced today a strategic collaboration...

Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe More

MassARRAY^® System with Chip Prep Module receives CE-IVD marking for general in vitro diagnostic use in EuropeSAN...

Agena Bioscience Announces Expanded Partnership With Assurex Health More

MassARRAY^® System Selected for Assurex Health’s GeneSight TestSAN DIEGO, Calif., June 20, 2017– Agena...

Agena Bioscience Introduces New Lung and Colon Cancer Panels for Detection of Somatic Mutations from Liquid Biopsies and Solid Tumor Tissues More

SAN DIEGO, Calif., March 15, 2017 — Agena Bioscience today introduced new targeted research panels for the detection of...

Multiplexed Analysis of ALK, ROS1, and RET Rearrangements in Lung Cancer Enabled by the MassARRAY^® System More

SAN DIEGO, Calif., February 9, 2017 – Agena Bioscience today announced a comparative study published in Scientific Reports...

Agena Bioscience Names Genelex as Certified Service Provider for Targeted Genetic Analysis More

SAN DIEGO, Calif., August 29, 2016 — Agena Bioscience today announced the successful certification of Genelex as a Certified...

David Coorey Joins Agena Bioscience to Lead Europe, Middle East, and Africa Business More

SAN DIEGO, Calif., July 11, 2016 — Agena Bioscience today announced the appointment of David Coorey as Vice President...

Agena Bioscience Launches High Sensitivity and Multiplexed Genetic Testing Product for Targeted Analysis of Solid Tumors More

iPLEX^® HS chemistry enables multiplex detection down to 1% allele frequencySAN DIEGO, Calif., April 18, 2016...

Agena Bioscience Launches in vitro Diagnostic Tests for Lung and Colon Cancer in Europe More

Company achieves CE-IVD mark and enters routine molecular diagnostics marketSAN DIEGO, Calif. and Hamburg, Germany, April...

Agena Bioscience and CapitalBio Technology to Develop Cost-Effective Genetic Testing for Commercial Agricultural Applications More

SAN DIEGO, Calif., March 1, 2016 - Agena Bioscience (Agena) today announced its partnership to co-develop commercial tests...

Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China More

SAN DIEGO, Calif., February 1, 2016 - Agena Bioscience today announced its partnership with DaRui Biotechnology to co-develop...